# CereVasc

**Canonical:** https://apis.io/providers/cerevasc/  
**Website:** https://cerevasc.com/  
**APIs profiled:** 0

CereVasc, Inc. is a clinical-stage medical device company developing novel, minimally invasive treatments for patients with neurological diseases. Its lead product, the eShunt System, uses percutaneous transvenous-transdural access to the central nervous system to treat communicating hydrocephalus — including normal pressure hydrocephalus (NPH) — as a less invasive alternative to conventional neurosurgical shunt placement. The eShunt System is an investigational device limited by United States federal law to investigational use, and is being evaluated in the STRIDE pivotal study (NCT06498960). CereVasc raised a $70M Series B in 2024 and has received FDA Breakthrough Device Designation. The company builds implantable hardware and publishes no public API, developer program, or machine-readable specification.

## Kin Score — 8.3 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 8.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.2 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Cerevasc Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Medical Devices, Healthcare, Neurology, Hydrocephalus, Medical Technology, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/cerevasc/). Scores are computed from the provider's own public artifacts under a published rubric.